Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 28;8(8):248.
doi: 10.3390/biomedicines8080248.

Extracellular Vesicles in Acute Stroke Diagnostics

Affiliations
Review

Extracellular Vesicles in Acute Stroke Diagnostics

Katrine Tang Stenz et al. Biomedicines. .

Abstract

There is a large unmet need for fast and reliable diagnostics in several diseases. One such disease is stroke, where the efficacy of modern reperfusion therapies is highly time-dependent. Diagnosis of stroke and treatment initiation should be performed as soon as possible, and preferably before arrival at the stroke center. In recent years, several potential blood biomarkers for stroke have been evaluated, but without success. In this review, we will go into detail on the possibility of utilizing extracellular vesicles (EVs) released into the blood as novel biomarkers for stroke diagnostics. EVs are known to reflect the immediate state of the secreting cells and to be able to cross the blood-brain barrier, thus making them attractive as diagnostic biomarkers of brain diseases. Indeed, several studies have reported EV markers that enable differentiation between stroke patients and controls and, to a lesser extent, the ability to correctly classify the different stroke types. Most of the studies rely on the use of sophisticated and time-consuming methods to quantify specific subpopulations of the nanosized EVs. As these methods cannot be easily implemented in a rapid point of care (POC) test, technical developments followed by prospective clinical studies are needed.

Keywords: circulating biomarkers; diagnostics; extracellular vesicles; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

References

    1. Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Das S.R., et al. Heart disease and stroke statistics—2019 Update: A report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659. - DOI - PubMed
    1. Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K., Biller J., Brown M., Demaerschalk B.M., Hoh B., et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi: 10.1161/str.0000000000000211. - DOI - PubMed
    1. Meretoja A., Keshtkaran M., Tatlisumak T., Donnan G.A., Churilov L. Endovascular therapy for ischemic stroke. Neurology. 2017;88:2123–2127. doi: 10.1212/WNL.0000000000003981. - DOI - PubMed
    1. Saver J.L. Time Is Brain—Quantified. Stroke. 2006;37:263–266. doi: 10.1161/01.STR.0000196957.55928.ab. - DOI - PubMed
    1. Spilg E.G., Stott D.J., Rumley A., Bell L., Campbell A.M., Mansoor M.A., Lowe G.D.O. Homocysteine in Ischaemic stroke and vascular dementia. Age Ageing. 1998;27:50. doi: 10.1093/ageing/27.suppl_2.50-a. - DOI